Assessing the Validity of Normalizing Aflatoxin B 1 -Lysine Albumin Adduct Biomarker Measurements to Total Serum Albumin Concentration across Multiple Human Population Studies.

MLA

Smith, Joshua W., et al. “Assessing the Validity of Normalizing Aflatoxin B 1 -Lysine Albumin Adduct Biomarker Measurements to Total Serum Albumin Concentration across Multiple Human Population Studies.” Toxins, vol. 14, no. 3, Mar. 2022, p. 162. EBSCOhost, https://doi.org/10.3390/toxins14030162.

APA

Smith, J. W., Ng, D. K., Alvarez, C. S., Egner, P. A., Burke, S. M., Chen, J.-G., Kensler, T. W., Koshiol, J., Rivera-Andrade, A., Kroker-Lobos, M. F., Ramírez-Zea, M., McGlynn, K. A., & Groopman, J. D. (2022). Assessing the Validity of Normalizing Aflatoxin B 1 -Lysine Albumin Adduct Biomarker Measurements to Total Serum Albumin Concentration across Multiple Human Population Studies. Toxins, 14(3), 162. https://doi.org/10.3390/toxins14030162

Chicago

Smith, Joshua W., Derek K. Ng, Christian S. Alvarez, Patricia A. Egner, Sean M. Burke, Jian-Guo Chen, Thomas W. Kensler, et al. 2022. “Assessing the Validity of Normalizing Aflatoxin B 1 -Lysine Albumin Adduct Biomarker Measurements to Total Serum Albumin Concentration across Multiple Human Population Studies.” Toxins 14 (3): 162. doi:10.3390/toxins14030162.